Versor Investments’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-8,942
| Closed | -$236K | – | 955 |
|
2024
Q2 | $236K | Sell |
8,942
-30,617
| -77% | -$807K | 0.04% | 610 |
|
2024
Q1 | $1.2M | Buy |
39,559
+18,517
| +88% | +$562K | 0.24% | 103 |
|
2023
Q4 | $591K | Buy |
+21,042
| New | +$591K | 0.12% | 278 |
|
2023
Q3 | – | Sell |
-33,813
| Closed | -$1.04M | – | 820 |
|
2023
Q2 | $1.04M | Buy |
33,813
+11,013
| +48% | +$339K | 0.18% | 76 |
|
2023
Q1 | $821K | Sell |
22,800
-9,990
| -30% | -$360K | 0.11% | 166 |
|
2022
Q4 | $1.3M | Buy |
32,790
+13,490
| +70% | +$533K | 0.11% | 88 |
|
2022
Q3 | $775K | Buy |
+19,300
| New | +$775K | 0.05% | 308 |
|
2022
Q2 | – | Sell |
-7,746
| Closed | -$302K | – | 903 |
|
2022
Q1 | $302K | Sell |
7,746
-2,036
| -21% | -$79.4K | 0.01% | 485 |
|
2021
Q4 | $390K | Buy |
+9,782
| New | +$390K | 0.01% | 328 |
|